CELLULIS is a private R+D company engaged in developing novel technologies for the drug development and cell therapy markets. Our cryopreservation patented technologies provide innovative solutions to improve and standardize the entire cryopreservation process.
We are a group of scientists that joined forces in 2009 in order to create a brand new R+D biotechnology company. During these years we have developed several proprietary protocols resulting in products and services that are now commercially available. In this period we have also established several R+D projects, which are in different stages of development, that guarantee an ongoing flow of innovative products for the future.
A successful team
beats with one heart